- The latest 2 billion yuan funding comes just two months after Galaxea completed a nearly 1 billion yuan Series B round in February.
- The fresh capital will accelerate the mass production of its AI robots and drive further research and development of its vision-language-action foundation models.

Chinese robotics startup Galaxea announced it has raised nearly two billion yuan ($290 million) in Series B+ funding, marking one of the largest financing rounds in the sector.
The latest development comes just two months after its nearly one billion yuan Series B round in February, signaling strong capital market confidence in the industry.
The funding round attracted industrial capital including Walden International, Lens Technology, and Xixin Investment, alongside institutional players like Financial Street Capital and funds under CICC Capital, according to Galaxea's announcement on Thursday.
As a key partner of Lens Technology, the two companies will collaborate deeply in the hardware supply chain and the mass production of robots to accelerate product penetration across all scenarios, the company said.
Galaxea's core objective is to build a general embodied AI brain, integrating vision-language-action models with world action models to endow robots with a general intelligence to understand the physical world.
The company recently released its world model, Fast-WAM, which aims to improve inference speed through a reconstruction of the underlying architecture, Galaxea noted.
On the product front, Galaxea has launched the general-purpose humanoid robot R1 Pro and the wheeled dual-arm mobile platform R1 lite, while also building a full-stack embodied AI development platform.
With its supply chain and scenario capabilities fully maturing, Galaxea plans to officially initiate mass production at the 10,000-unit scale in 2026, accelerating the commercial application of embodied AI in the physical world, the company stated.